![Frederic Godderis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frederic Godderis
Directeur des opérations chez Tranquis Therapeutics, Inc.
Profil
Frederic Godderis currently works at Tranquis Therapeutics, Inc., as Chief Operating Officer from 2021.
Mr. Godderis received his graduate degree from Katholieke Universiteit Leuven.
Postes actifs de Frederic Godderis
Sociétés | Poste | Début |
---|---|---|
Tranquis Therapeutics, Inc.
![]() Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tranquis Therapeutics, Inc. discovers and develops novel immuno-therapeutics for neurological diseases. It offers treatment for central nervous system (CNS) disorders, including Amyotrophic Lateral Sclerosis, Parkinson 's disease, Alzheimer?s Disease, and age-related neuropathology. The company was founded by Chih-Ping Liu and Khoa D. Nguyen in June 2016 and is headquartered in Menlo Park, CA. | Directeur des opérations | 26/05/2021 |
Formation de Frederic Godderis
Katholieke Universiteit Leuven | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Tranquis Therapeutics, Inc.
![]() Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tranquis Therapeutics, Inc. discovers and develops novel immuno-therapeutics for neurological diseases. It offers treatment for central nervous system (CNS) disorders, including Amyotrophic Lateral Sclerosis, Parkinson 's disease, Alzheimer?s Disease, and age-related neuropathology. The company was founded by Chih-Ping Liu and Khoa D. Nguyen in June 2016 and is headquartered in Menlo Park, CA. | Health Technology |